Maslimomab is a mouse monoclonal antibody[1] and an immunosuppressive drug.[2] It is an anti-human T-cell receptor alpha/beta chain.[1]

Maslimomab
Monoclonal antibody
Type?
SourceMouse
TargetT-cell receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ a b "Proposed International Nonproprietary Names: Maslimomab" (PDF). WHO Drug Information. 5 (4). Geneva: World Health Organization: 201. 1991. Archived from the original (PDF) on 23 February 2012.
  2. ^ Pelletier JP, Mukhtar F (January 2020). "Passive monoclonal and polyclonal antibody therapies.". Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. pp. 251–348 (299). doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. PMC 7153350.